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b-Adrenergic Stimulation Induces Histone Deacetylase 5 (HDAC5)
Nuclear Accumulation in Cardiomyocytes by B55a-PP2A-Mediated
Dephosphorylation
Kate L. Weeks, PhD;* Antonella Ranieri, PhD; Agnieszka Karas, BSc; Bianca C. Bernardo, PhD; Alexandra S. Ashcroft, BSc; Chris Molenaar,
PhD; Julie R. McMullen, PhD; Metin Avkiran, PhD, DSc
Background-—Class IIa histone deacetylase (HDAC) isoforms such as HDAC5 are critical signal-responsive repressors of
maladaptive cardiomyocyte hypertrophy, through nuclear interactions with transcription factors including myocyte enhancer
factor-2. b-Adrenoceptor (b-AR) stimulation, a signal of fundamental importance in regulating cardiac function, has been proposed
to induce both phosphorylation-independent nuclear export and phosphorylation-dependent nuclear accumulation of cardiomy-
ocyte HDAC5. The relative importance of phosphorylation at Ser259/Ser498 versus Ser279 in HDAC5 regulation is also
controversial. We aimed to determine the impact of b-AR stimulation on the phosphorylation, localization, and function of
cardiomyocyte HDAC5 and delineate underlying molecular mechanisms.
Methods and Results-—A novel 3-dimensional confocal microscopy method that objectively quantiﬁes the whole-cell nuclear/
cytoplasmic distribution of green ﬂuorescent protein tagged HDAC5 revealed the b-AR agonist isoproterenol to induce b1-AR-
mediated and protein kinase A-dependent HDAC5 nuclear accumulation in adult rat cardiomyocytes, which was accompanied by
dephosphorylation at Ser259/279/498. Mutation of Ser259/Ser498 to Ala promoted HDAC5 nuclear accumulation and myocyte
enhancer factor-2 inhibition, whereas Ser279 ablation had no such effect and did not block isoproterenol-induced nuclear
accumulation. Inhibition of the Ser/Thr phosphatase PP2A blocked isoproterenol-induced HDAC5 dephosphorylation. Co-
immunoprecipitation revealed a speciﬁc interaction of HDAC5 with the PP2A targeting subunit B55a, as well as catalytic and
scaffolding subunits, which increased >3-fold with isoproterenol. Knockdown of B55a in neonatal cardiomyocytes attenuated
isoproterenol-induced HDAC5 dephosphorylation.
Conclusions-—b-AR stimulation induces HDAC5 nuclear accumulation in cardiomyocytes by a mechanism that is protein kinase
A-dependent but requires B55a-PP2A-mediated dephosphorylation of Ser259/Ser498 rather than protein kinase A-mediated
phosphorylation of Ser279. ( J Am Heart Assoc. 2017;6:e004861. DOI: 10.1161/JAHA.116.004861.)
Key Words: adrenergic stimulation • B55a • confocal imaging • histone deacetylase 5 • hypertrophy/remodeling
• microscopy • phosphatase • phosphorylation • PP2A • three dimensional • b-adrenergic signaling
H istone deacetylase (HDAC) 5 is a class IIa HDAC isoformthat is an important negative regulator of maladaptive
cardiomyocyte hypertrophy and pathological cardiac remodel-
ing.1 Unlike class I HDACs, which repress gene transcription by
altering chromatin structure via the deacetylation of histones,
class IIa HDACs regulate transcription via the direct repression
of transcription factors, such as members of the myocyte
enhancer factor-2 (MEF2) family,2 and by recruiting epigenetic
regulators (such as class I HDACs and histone methyltrans-
ferases) to DNA in large, multiprotein repressor complexes.3–6
Nuclear export of class IIa HDACs leads to dissociation of these
repressor complexes, which promotes gene transcription by
permitting the recruitment of transcriptional activators (such as
histone acetyltransferases and histone demethylases) and the
From the Cardiovascular Division, King’s College London British Heart Foundation Centre of Research Excellence, The Rayne Institute, St Thomas’ Hospital, London,
United Kingdom (K.L.W., A.R., A.K., A.S.A., C.M., M.A.); Baker Heart and Diabetes Institute, Melbourne, Australia (K.L.W., B.C.B., J.R.M.).
AccompanyingDataS1and FiguresS1 through S9are available at http://jaha.ahajournals.org/content/6/4/e004861/DC1/embed/inline-supplementary-material-1.pdf
*Dr Kate L. Weeks is currently located at the Baker Heart and Diabetes Institute, Melbourne, Australia.
Correspondence to: Metin Avkiran, PhD, DSc, Cardiovascular Division, King’s College London, The Rayne Institute, St Thomas’ Hospital, Westminster Bridge Road,
London SE1 7EH, United Kingdom. E-mail: metin.avkiran@kcl.ac.uk
Received January 16, 2017; accepted February 14, 2017.
ª 2017 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell. This is an open access article under the terms of the Creative
Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
DOI: 10.1161/JAHA.116.004861 Journal of the American Heart Association 1
ORIGINAL RESEARCH
 by guest on January 12, 2018
http://jaha.ahajournals.org/
D
ow
nloaded from
 
binding of transcription factors to gene promoter/enhancer
regions.5 Thus, subcellular localization is a key determinant of
class IIa HDAC function.
HDAC5 contains at least 17 phospho-acceptor residues7
and altered phosphorylation is a key posttranslational mech-
anism regulating its nuclear/cytoplasmic distribution (see
recent reviews8,9). Of particular interest are S259 and S498
ﬂanking a nuclear localization sequence, whose phosphoryla-
tion alters HDAC5 localization in cardiomyocytes in response
to biologically relevant neurohormonal stimuli. Stimulation of
Gq protein-coupled receptors (GqPCRs), such as the a1-
adrenergic receptor or the endothelin-1 receptor, induces the
phosphorylation of S259/S498 by HDAC kinases, such as
protein kinase D10 and Ca2+/calmodulin-dependent protein
kinase II.11,12 This in turn triggers a conformational change
that exposes a C-terminal nuclear export sequence, leading to
CRM1-dependent nuclear export.11,13,14 Phosphorylated S259
and S498 also provide docking sites for 14-3-3 proteins,
which mask the nuclear localization sequence, preventing re-
entry into the nucleus.15,16 In contrast to GqPCR agonists, our
recent work indicates that stimulation of the Gs protein-
coupled b-adrenergic receptor (b-AR) with isoproterenol
reduces HDAC5 phosphorylation at S259/S498 in cardiomy-
ocytes, but may trigger HDAC5 nuclear export through a
phosphorylation-independent mechanism.17
In recent years, phosphorylation of S279 has also been
proposed as an important mechanism regulating HDAC5
subcellular localization in cardiomyocytes. S279 can be directly
phosphorylated by protein kinase A (PKA) in in vitro kinase
assays, and interventions that activate b-AR/PKA signaling
block GqPCR-mediated nuclear export of HDAC5 in neonatal rat
ventricularmyocytes (NRVM).18 Furthermore, data from the use
of phospho-mimetic (S279D) and nonphosphorylatable
(S279A) mutants of HDAC5 support a role for S279 phospho-
rylation in driving the nuclear retention of HDAC5 in this cell
type.18 Broadly similar ﬁndings were reported subsequently
from studies using adult rabbit ventricular myocytes.19 How-
ever, it is important to note that, to date, there is no evidence for
increased HDAC5 phosphorylation at S279 occurring in
response to b-AR-mediated PKA activation in cardiomyocytes.
Given that b-AR signaling is a key therapeutic target in heart
failure because of its critical role in the regulation of cardiac
structure and function,20,21 we set out to address the following
principal aims: (1) To deﬁnitively determine the impact of b-AR/
PKA signaling on the phosphorylation, subcellular localization,
and function of HDAC5 in adult cardiomyocytes; (2) To delineate
the relative importance of altered phosphorylation at S259/
S498 (established nuclear export sites) versus S279 (putative
nuclear import site) in regulating the subcellular distribution of
HDAC5 in this cell type; and (3) To determine the molecular
mechanisms responsible for altered phosphorylation at the key
regulatory residues. Toward these aims, we developed a new
imaging method that allows the comprehensive quantiﬁcation
of the whole-cell nuclear/cytoplasmic distribution of green
ﬂuorescent protein (GFP) tagged HDAC5 in living adult rat
ventricular myocytes (ARVM), utilizing ﬂuorescent dyes for
objective demarcation of the nuclear and cytoplasmic com-
partments in conjunction with 3-dimensional confocal micro-
scopy. Our data show that b-AR stimulation induces the nuclear
accumulation of HDAC5 through a mechanism that is mediated
by the b1-AR subtype and PKA activity. Furthermore, our data
indicate that b-AR stimulation induces PP2A-mediated dephos-
phorylation of HDAC5 at both the S259/S498 and the S279
sites, and that reduced phosphorylation at the S259/S498
sites is the principal mechanismofb1-AR/PKA/PP2A-mediated
nuclear accumulation. Finally, we show that b-AR activation
increases the interaction between HDAC5 and PP2A catalytic
and scaffolding subunits, as well as the PP2A targeting subunit
B55a selectively. Silencing of B55a in NRVM blocked isopro-
terenol-induced dephosphorylation at the S259 site, suggesting
that this subunit is required for PP2A-mediated dephosphory-
lation of HDAC5 downstream of b-AR activation in cardiomy-
ocytes. These ﬁndings point to a role for B55a-PP2A-mediated
HDAC5 dephosphorylation and nuclear accumulation in pre-
venting MEF2-dependent gene transcription during short-term
b-AR stimulation.
Methods
Detailed methodology is provided in Data S1. Data are
presented as meanSEM, unless otherwise stated in the
ﬁgure legend. Normally distributed data sets were analyzed by
unpaired t test, 1-way ANOVA or 2-way ANOVA as appropri-
ate. Data sets that failed the D’Agostino and Pearson omnibus
normality test were analyzed by Mann–Whitney test (2
groups) or Kruskal–Wallis 1-way ANOVA by ranks (2 or more
groups). ARVM experiments were performed in accordance
with the Guidance on the Operation of Animals (Scientiﬁc
Procedures) Act, 1986 (UK). NRVM experiments were con-
ducted in accordance with the Australian Code for the Care
and Use of Animals for Scientiﬁc Purposes (National Health &
Medical Research Council of Australia, 8th Edition, 2013) and
were approved by the Alfred Medical Research and Education
Precinct’s Animal Ethics Committee.
Results
b1-AR/PKA Activation Induces Dephosphorylation
of HDAC5 at S259/S498 and S279
To investigate the effects of b-AR stimulation on the
phosphorylation status of HDAC5 at S279, we made use of
a recently described rabbit polyclonal antibody that detects
phosphorylation of the conserved serine residue (S266) in
DOI: 10.1161/JAHA.116.004861 Journal of the American Heart Association 2
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HDAC4.22 As the phospho-peptide sequence used to generate
the anti-pS266 HDAC4 antibody shares 100% amino acid
identity with the pS279 motif in HDAC5 (Figure S1A), we
predicted that this antibody would cross-react with phospho-
rylated S279 in HDAC5. This was indeed the case, with the
antibody detecting a protein of the correct molecular weight
(150 kDa) in ARVM expressing wildtype (WT) GFP-HDAC5 or
GFP-HDAC5 in which the S259 and S498 residues were
mutated to alanine (S259/498A), but not in ARVM expressing
GFP alone or a S279A mutant of GFP-HDAC5 (Figure S1B). We
also conﬁrmed the phospho-speciﬁcity of 2 commercially
available antibodies (3443 from Cell Signaling and 47283
from Abcam) that detect pS259 or pS498 (Figure S1B; signals
in ARVM expressing WT or S279A GFP-HDAC5, but not in
ARVM expressing S259/498A GFP-HDAC5 or GFP alone).
Consistent with our previous report,17 stimulation of ARVM
expressing WT GFP-HDAC5 with 10 nmol/L isoproterenol
resulted in a rapid reduction in phosphorylation of S259 and
S498 (Figure 1A). The maximum response occurred after
10 minutes and was sustained for at least 60 minutes.
Interestingly, the proposed PKA target site, S279, responded
in a similar manner, exhibiting marked dephosphorylation
(Figure 1A). To investigate whether these effects occurred
downstream of the b1- or b2-AR, ARVM were treated with
CGP-20712A (a b1-AR-selective antagonist) or ICI 118,551 (a
b2-AR-selective antagonist) for 10 minutes prior to isopro-
terenol stimulation. CGP-20712A blocked both isoproterenol-
induced dephosphorylation of HDAC5 at all 3 sites and
isoproterenol-induced phosphorylation of cardiac troponin I
(cTnI) at S22/S23, established PKA target sites that are
phosphorylated downstream of b1-AR stimulation (Figure 1B).
Treating cells with ICI 118,551 at an identical concentration
(CGP-20712A and ICI 118,551 have comparable Ki values for
their target b-AR subtypes23) had no effect on isoproterenol-
induced HDAC5 dephosphorylation or cTnI phosphorylation
(Figure 1B). These data indicate that HDAC5 dephosphoryla-
tion following isoproterenol stimulation occurs downstream of
the b1-AR subtype.
Next, we investigated the role of the cAMP-activated
effectors PKA and Epac in this b1-AR-mediated response.
Directly activating PKA with the PKA-selective cAMP ana-
logue N6-benzoyl cAMP induced a similar degree of cTnI
phosphorylation at S22/S23 as 10 nmol/L isoproterenol,
indicating comparable PKA activation (Figure S2A). N6-
benzoyl cAMP treatment also resulted in robust dephospho-
rylation of HDAC5 at all 3 sites, similar to that observed with
isoproterenol (Figure 1C). In contrast, an identical
concentration of the Epac-selective cAMP analogue, 8-CPT-
20-O-Me-cAMP (CPT), had no effect on cTnI or HDAC5
phosphorylation status (Figure S2B and S2C). These ﬁndings
indicate that PKA activation alone is sufﬁcient to induce
HDAC5 dephosphorylation.
b1-AR/PKA Signaling Induces Nuclear
Accumulation of HDAC5
b-AR stimulation with isoproterenol has been reported to
induce both nuclear export17 and nuclear accumulation19 of
GFP-HDAC5 in adult cardiomyocytes. To deﬁnitively delineate
the impact of b-AR stimulation on GFP-HDAC5 distribution in
this cell type, we established a new imaging method for
assessing the nuclear and cytoplasmic contents of GFP-
HDAC5 in living ARVM. Previous methods for quantifying the
relative abundance of GFP-HDAC5 (and other GFP-tagged
proteins) in nuclear versus cytoplasmic compartments of
adult cardiomyocytes have used either wideﬁeld ﬂuorescence
microscopy17,24 or confocal microscopy of a single z-
section19,25 to image GFP ﬂuorescence within selected
regions before and after exposure to various stimuli. Each
of these studies utilized the GFP ﬂuorescence signal to select
and focus the cells for imaging, and to deﬁne nuclear and
cytoplasmic regions of interest within which the average
ﬂuorescence intensity (F) was quantiﬁed. In preliminary
experiments using z-stack confocal microscopy, we found
that the focal plane had a signiﬁcant impact on the measured
ﬂuorescence intensity, particularly within the nuclear com-
partment (Fnuc; Figure S3A and S3B) but also within the
cytoplasmic compartment (Fcyto; Figure S3C). Fnuc also often
varied markedly between different nuclei in individual binu-
cleated cells (Figure S3B).
To eliminate the variability and potential subjectivity
associated with sampling small regions of interest, and to
account for differences in the focal plane between cells or
focal drift over the time course of an experiment, we used
spinning disk confocal microscopy to acquire z-stacks (1.5-
lm steps spanning 36 lm) to capture information from the
whole cell. Cells were imaged at baseline and at 15 and
45 minutes after the addition of vehicle control or isopro-
terenol, to allow the assessment of the temporal effects of
each treatment. Additionally, myocytes were labeled with
Cell Tracker Orange the day before imaging, and nuclei
were labeled with DRAQ5 10 minutes before the ﬁnal time
point. Images subsequently obtained during excitation of
the Cell Tracker Orange and DRAQ5 ﬂuorophores with a
laser beam at 561 or 640 nm, respectively, were used to
objectively delineate the cytoplasmic and nuclear compart-
ments (Figure 2A). This allowed quantiﬁcation of the GFP
ﬂuorescence signal in each compartment (Fcyto and Fnuc) in
an unbiased manner and calculation of the nuclear/
cytoplasmic F ratio (Fnuc/Fcyto) at each time point. For
time course experiments, Fnuc/Fcyto ratios obtained at the
15- and 45-minute time points were normalized to the
baseline value for each cell, to account for differences in
the basal distribution of GFP-HDAC5 between cells. Strict
inclusion criteria were adhered to during the selection of
DOI: 10.1161/JAHA.116.004861 Journal of the American Heart Association 3
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cells for imaging and the postimaging quantiﬁcation of
signals was conducted in a treatment-blinded manner (see
Methods for further details).
The application of the above methodology revealed
isoproterenol to induce signiﬁcant nuclear accumulation of
GFP-HDAC5 (Figure 2A), quantiﬁed as an increase in Fnuc
kDa
150
150
150
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pS279 HDAC5
pS498 HDAC5
GFP-HDAC5
0     2   5 10    30 60
ISO stimulation (min)
pS259 HDAC5
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25
25
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– +
CGP ICIVEH
– + – +ISO:
pS279 HDAC5
pS498 HDAC5
GFP-HDAC5
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pS22/23 cTnI
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25
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CON   BNZ
pS259 HDAC5
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150
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Figure 1. b1-AR/PKA activation reduces HDAC5 phosphorylation. A, Time course of HDAC5 dephos-
phorylation by 10 nmol/L isoproterenol (ISO). Representative Western blots and grouped data from 4
independent experiments. Data obtained for each phosphorylation site were analyzed by 1-way ANOVA
followed by Dunnett’s multiple comparisons tests. *P<0.05 vs 0 minutes. B, ARVM were treated with
10 nmol/L ISO or vehicle control (CON) for 10 minutes in the presence of 100 nmol/L CGP-20712A (CGP;
a b1-AR-selective antagonist), 100 nmol/L ICI 118,551 (ICI; a b2-AR-selective antagonist), or vehicle (VEH).
Representative Western blots and grouped data from 6 independent experiments. One-way ANOVA followed
by Dunnett’s multiple comparisons tests for each phosphorylation site. *P<0.05 vs VEH. C, ARVM were
treated with 500 lmol/L N6-benzoyl cAMP (BNZ) to selectively activate PKA or vehicle control (CON) for
30 minutes. Representative Western blots and grouped data from 5 independent experiments (n=4 for
S498 site). Unpaired t test for each phosphorylation site. *P<0.05 vs CON. b1-AR indicates b-adrenergic
receptor; ARVM, adult rat ventricular myocytes; BNZ, N6-benzoyl cAMP; cTnI, cardiac troponin I; HDAC5,
histone deacetylase 5; PKA, protein kinase A.
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(Figure 2B) and a decrease in Fcyto (Figure 2C) and a
corresponding increase in the Fnuc/Fcyto ratio (see vehicle-
treated control and isoproterenol groups, Figure 3A and 3B).
Importantly, there was no change in the whole cell
ﬂuorescence (Fcell) over the course of the experiment
(Figure 3C). To validate our ﬁndings, we determined the
distribution of GFP-HDAC5 in ARVM by a fractionation
approach. Brieﬂy, ARVM were fractionated into Triton X-100-
A
D
B
GFP-HDAC5 Baseline
Cell Tracker 45 min DRAQ5 45 min
GFP-HDAC5 45 min ISO
Fnuc
Fcyto
Fcell
88.3
17.5
19.9
Fnuc
Fcyto
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133.5
16.0
19.9
kDa
GFP-HDAC5
GAPDH
Histone 2B
INPUT SOL INSOL
CON ISO CON ISO CON ISO
150 
37 
15 
C
Figure 2. b-adrenergic stimulation induces nuclear accumulation of GFP-HDAC5. A, 3-Dimensional
projections of an ARVM expressing GFP-HDAC5 at baseline and 45 minutes after the addition of 10 nmol/L
isoproterenol (ISO). Z-stacks (25 z-sections at 1.5-lm intervals) were acquired as described in the Methods
section. The ﬂuorescent signals from the Cell Tracker Orange and DRAQ5 dyes were used to deﬁne the
cytoplasmic (cyto) and nuclear (nuc) volumes for objective quantiﬁcation of the average ﬂuorescence
intensity (F) arising from the GFP-HDAC5 signal within those compartments. B and C, Quantiﬁcation of Fnuc
and Fcyto following treatment with 10 nmol/L ISO or vehicle control (CON) for 15 to 45 minutes. All
measurements obtained at the 15- and 45-minute time points were normalized to the baseline value for
each cell (denoted by the dotted line). Two-way repeated-measures ANOVA followed by Sidak’s multiple
comparisons tests. *P<0.05 vs CON at the same time point. †P<0.05 vs the same treatment group at the
15-minute time point. n=17 to 22 cells from 3 hearts per group. D, ARVM were fractionated into Triton X-
100-soluble (SOL) and -insoluble (INSOL) fractions via centrifugation following treatment with 10 nmol/L
ISO or CON for 45 minutes. Representative Western blots show the distribution of GFP-HDAC5, GAPDH
(cytosolic protein), and histone 2B (nuclear protein). Quantitative data show GFP-HDAC5 abundance in
soluble and insoluble fractions from 5 independent experiments. In each experiment, the GFP-HDAC5 signal
in CON and ISO fractions was normalized to the respective input. Unpaired t tests. *P<0.05 vs CON. ARVM
indicates adult rat ventricular myocytes; GFP, green ﬂuorescent protein; HDAC5, histone deacetylase 5.
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soluble and -insoluble fractions via centrifugation. Treatment
with isoproterenol resulted in depletion of GFP-HDAC5 from
the soluble fraction, which contained cytosolic proteins such
as GAPDH, and an enrichment of GFP-HDAC5 in the insoluble
fraction, which contained nuclear proteins such as histone 2B
(Figure 2D). These data conclusively demonstrate that acute
b-adrenergic stimulation triggers the nuclear accumulation of
GFP-HDAC5 in adult cardiomyocytes.
Next, we investigated the importance of PKA in regulating
this process. The isoproterenol-induced nuclear accumulation
of GFP-HDAC5 was blocked by pretreatment with H89
(Figure 3A and 3B), an isoquinolinesulfonamide that sup-
presses PKA activity through competitive inhibition at the ATP
binding site of the kinase.26 Fcell did not change signiﬁcantly
in response to isoproterenol and/or H89 treatment over the
course of these experiments (Figure 3C). Biochemical analy-
ses revealed such pretreatment with H89 to inhibit isopro-
terenol-induced cTnI phosphorylation, conﬁrming effective
inhibition of PKA activity, as well as isoproterenol-induced
HDAC5 dephosphorylation (Figure 3D). Taken together, these
ﬁndings indicate that PKA activity is necessary for both
isoproterenol-induced dephosphorylation and isoproterenol-
induced nuclear accumulation of HDAC5.
S279 Phosphorylation Is Not Required for HDAC5
Nuclear Accumulation
As noted earlier, it has been proposed that PKA-mediated
phosphorylation of S279 drives the nuclear import of HDAC5
following b-AR activation.19 However, in our experiments,
HDAC5
cTnI
A B C
pS259 HDAC5
GFP-
pS22/23 
cTnI
– +
H89VEH
– +ISO:
kDa
150
150
25
25
D
Figure 3. ISO-induced dephosphorylation and nuclear accumulation of HDAC5 is PKA-dependent. A and B, Quantiﬁcation of the nuclear/
cytoplasmic ﬂuorescence ratio (Fnuc/Fcyto) in ARVM treated with 10 nmol/L ISO or CON in the presence of 10 lmol/L H89 (PKA inhibitor) or
vehicle (VEH). Fnuc/Fcyto ratios were normalized to the baseline value obtained for each cell to account for differences in the basal distribution of
GFP-HDAC5 between cells. Two-way ANOVA followed by Tukey’s multiple comparisons test. *P<0.05 vs CON within the same pretreatment
group (VEH/H89). †P<0.05 vs VEH within the same treatment group (CON/ISO). n=17 to 30 cells from 3 hearts per group. C, Quantiﬁcation of
Fcell at the 45-minute time point, normalized to baseline. No signiﬁcant differences were detected by 2-way ANOVA. D, ARVM were treated with
10 nmol/L ISO or CON in the presence of 10 lmol/L H89 or vehicle (VEH). Representative Western blots and grouped data from 5 independent
experiments. Unpaired t test. *P<0.05 vs VEH. ARVM indicates adult rat ventricular myocytes; CON, control; cTnI, cardiac troponin I; GFP, green
ﬂuorescent protein; HDAC5, histone deacetylase 5; ISO, isoproterenol; PKA, protein kinase A.
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isoproterenol stimulation induced dephosphorylation of S279,
as well as S259/S498 (Figure 1), while also triggering the
nuclear accumulation of HDAC5 (Figures 2 and 3). To
determine the relative importance of altered phosphorylation
at S279 versus S259/S498 in regulating the subcellular
distribution of HDAC5, we imaged cells expressing nonphos-
phorylatable mutants of GFP-HDAC5 (S259/498A and
S279A). Under basal conditions, S259/498A GFP-HDAC5
was more nuclear than WT GFP-HDAC5, whereas the S279A
mutant displayed a similar subcellular distribution to WT GFP-
HDAC5 (Figure 4A). Fcell did not differ signiﬁcantly between
the groups (Figure 4B), consistent with the fact that we
expressed the variants to similar levels (Figure 4C).
In complementary experiments, we also investigated the
impact of expressing each GFP-HDAC5 variant on MEF2
activity in ARVM co-expressing a luciferase reporter under the
transcriptional control of a MEF2-sensitive promoter. MEF2 is
a well-characterized binding partner of HDAC5, and disruption
of their interaction following phosphorylation-dependent
nuclear export of HDAC5 permits MEF2-dependent gene
transcription that promotes maladaptive cardiomyocyte
hypertrophy.13,15,27 Relative to the heterologous expression
of GFP alone, that of WT GFP-HDAC5 repressed MEF2 activity
(Figure 4D). Expression of the S259/498A variant, which
showed greater nuclear accumulation (Figure 4A), led to a
further reduction in MEF2 activity (Figure 4D). In contrast,
expression of the S279A variant, which showed comparable
subcellular distribution to the WT protein (Figure 4A), had a
similar inhibitory effect on MEF2 activity (Figure 4D). These
data suggest that the phosphorylation status of S279 does
not have a signiﬁcant impact on the subcellular distribution of
HDAC5 or its function as a repressor of MEF2 transcriptional
BA C
D E F
WT
GFP-HDAC5
S259/
498A S279A GFP
Coomassie
150
250
150
kDa
Figure 4. The phosphorylation status of S259/S498, and not S279, is the key determinant of GFP-HDAC5 localization in ARVM. A and B,
Fnuc/Fcyto and Fcell for ARVM expressing wildtype (WT) or nonphosphorylatable variants (S259/498A, S279A) of GFP-HDAC5. All individual data
points, as well as the median and interquartile range, are shown. Kruskal-Wallis 1-way analysis of ranks followed by Dunn’s multiple comparisons
test. *P<0.05, n=69 to 98 cells from 3 to 6 hearts per group. C, Western blot showing comparable expression of GFP-HDAC5 variants in ARVM.
D, ARVM expressing GFP-HDAC5 variants or GFP alone were cotransduced with adenoviruses encoding a MEF2-luciferase reporter. ARVM were
lysed and the luminescence readings from 25 lg protein were normalized to an internal control (ARVM expressing the luciferase reporter but
not GFP/GFP-HDAC5). One-way ANOVA followed by Tukey’s multiple comparisons test. *P<0.05 vs GFP, †P<0.05 vs WT. n=6 to 7
independently transduced samples from 2 hearts per group. E and F, ARVM expressing WT or nonphosphorylatable GFP-HDAC5 variants were
treated with 10 nmol/L isoproterenol (ISO) or vehicle control (CON) for 45 minutes. Fnuc/Fcyto ratios and Fcell values were normalized to the
baseline value obtained for each cell to account for differences in the basal distribution of GFP-HDAC5 between cells. Two-way ANOVA followed
by Tukey’s multiple comparisons test. *P<0.05 vs CON for the same GFP-HDAC5 variant. †P<0.05 vs WT ISO, ‡P<0.05 vs S259/498A ISO. n=17
to 40 cells from 3 hearts per group. ARVM indicates adult rat ventricular myocytes; GFP, green ﬂuorescent protein; HDAC5, histone deacetylase
5; MEF, myocyte enhancing factor.
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activity under basal conditions. On studying the impact of
isoproterenol stimulation on the subcellular distribution of
these HDAC5 variants, we found such stimulation to have no
effect on S259/498A GFP-HDAC5 localization, but to induce
signiﬁcant nuclear accumulation of S279A GFP-HDAC5, albeit
to a lesser extent than WT GFP-HDAC5 (Figure 4E). Once
again, there was no treatment effect on Fcell in any study
group (Figure 4F). These ﬁndings indicate that the phospho-
rylation status of S259/S498 is the critical determinant of
HDAC5 subcellular localization, and thereby HDAC5-mediated
MEF2 inhibition, and suggest that b1-AR/PKA-mediated
dephosphorylation of these sites is responsible for isopro-
terenol-induced HDAC5 nuclear accumulation. Our data also
indicate that S279 phosphorylation is not necessary for
isoproterenol-induced HDAC5 nuclear import, ﬁrstly because
no increase is observed in S279 phosphorylation of WT GFP-
HDAC5 over the time course during which its nuclear
accumulation is observed (when, in fact, S279 becomes
dephosphorylated) and secondly because isoproterenol stim-
ulation induces signiﬁcant nuclear accumulation of HDAC5
even when the S279 phosphorylation site has been ablated.
PP2A Dephosphorylates HDAC5 Downstream of
b-AR Stimulation
Given the apparent mechanistic importance of HDAC5
dephosphorylation at S259/S498 in facilitating b1-AR/PKA-
mediated HDAC5 nuclear accumulation, we also explored the
mechanism(s) by which such dephosphorylation might occur.
Since isoproterenol-induced dephosphorylation occurs very
rapidly (within 2–5 minutes; Figure 1A), recruitment or acti-
vation of a protein phosphatase, rather than attenuated
activity of an HDAC kinase, such as protein kinase D,28,29 is
likely to be involved. On the basis of previous studies in other
cell types that have implicated PP2A activity as an important
regulator of the phosphorylation and subcellular distribution
of various class IIa HDAC isoforms30–33 and work in HEK 293
cells that identiﬁed isoforms of all 3 subunits of the PP2A
holoenzyme as binding partners of HDAC5,7 we hypothesized
that PP2A may function as an HDAC5 phosphatase in ARVM.
To test this, we treated cells with okadaic acid (OKA), a
marine-sponge toxin that inhibits the catalytic activity of both
PP1 and PP2A family enzymes but exhibits higher afﬁnity for
the latter,34 prior to isoproterenol stimulation. Pretreatment
with OKA at 100 nmol/L, but not 30 nmol/L, inhibited the
isoproterenol-induced dephosphorylation of HDAC5 at all 3
sites (Figure 5). OKA also increased the basal phosphorylation
of cTnI at S22/S23, which are known PP2A substrates,35 with
a similar concentration-response proﬁle. In contrast, OKA had
no effect on the phosphorylation of phospholamban (PLN) at
S16, which is a known PP1 substrate,36 indicating that
100 nmol/L OKA was sufﬁcient and necessary to selectively
inhibit PP2A activity in our experimental system. These
ﬁndings suggest that PP2A activity is required for isopro-
terenol-induced dephosphorylation of HDAC5.
B55a Targets PP2A to HDAC5 for
Dephosphorylation
PP2A family members are holoenzymes, each consisting of a
scaffolding (A) subunit, a catalytic (C) subunit, and a
regulatory (B) subunit, with substrate speciﬁcity conferred
by the identity of the B subunit isoform.37 The B subunit
isoform B55a (also known as PR55a; encoded by PPP2R2A)
has been identiﬁed previously as a component of the PP2A
complex that associates with heterologously expressed
HDAC5 in HEK 293 cells.7 The same group also identiﬁed
B55a as an interaction partner for HDAC5, but not any of 10
kDa
150
150
pS279 HDAC5
pS498 HDAC5
GFP-HDAC5
pS259 HDAC5
pS22/23 cTnI
cTnI
25
25
pS16 PLN
PLN
– +
30 1000
– + – +ISO (10 nM):
OKA (nM):
150
10
10
150
Figure 5. PP2A dephosphorylates HDAC5 downstream of b-AR
activation. ARVM were treated with 10 nmol/L isoproterenol
(ISO) or vehicle control for 10 minutes in the presence of vehicle
(VEH), 30 or 100 nmol/L okadaic acid (OKA). Representative
Western blots and grouped data from 5 independent experiments.
One-way ANOVA followed by Dunnett’s multiple comparisons
tests for each phosphorylation site. *P<0.05 vs VEH. b-AR
indicates b-adrenergic receptor; ARVM, adult rat ventricular
myocytes; cTnI, cardiac troponin I; GFP, green ﬂuorescent protein;
HDAC5, histone deacetylase 5; PLN, phospholamban; PP2A,
protein phosphatase 2A.
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other human HDACs, in a proteomics screen performed in T
cells heterologously expressing EGFP-tagged HDAC iso-
forms.38 These ﬁndings prompted us to investigate whether
B55a, which is expressed in the heart,39 might be responsible
for targeting the PP2A holoenzyme to HDAC5 in ARVM.
B55a was readily detectable in ARVM, using a commer-
cially available antibody (Figure S4A). To explore a potential
HDAC5/B55a interaction, we immuno-puriﬁed the GFP-
HDAC5 complex from ARVM following treatment with isopro-
terenol or vehicle control, and subjected it to SDS-PAGE and
immunoblot analysis. In pilot experiments we found that
B55a, but not two other B subunit isoforms (B56a and B56d),
was associated with GFP-HDAC5 in the absence and presence
of isoproterenol stimulation (Figure S4B). No such association
was observed with GFP (Figure S4B), indicating a speciﬁc
interaction with HDAC5. Replicate experiments focusing on
the potential interaction of HDAC5 with the B55a-PP2A
heterotrimeric holoenzyme revealed that not only B55a, but
also the C and A subunits of PP2A, associated with HDAC5
(Figure 6A). Consistent with our fractionation experiments
(Figure 2D), the amount of GFP-HDAC5 that could be
immunoprecipitated from the soluble cell lysate declined
following isoproterenol stimulation (Figure 6A, top panel),
presumably reﬂecting the accumulation of GFP-HDAC5 in the
nucleus, where it binds to DNA-associated partners such as
MEF2. Importantly, when normalized for the GFP-HDAC5
content of the immunoprecipitated complex, the relative
abundance of each of the components of the B55a-PP2A
holoenzyme within the complex increased >3-fold following
isoproterenol stimulation (Figure 6A, bottom panel). We
conﬁrmed that the interaction between B55a and HDAC5
also occurs with endogenous proteins by immunoprecipitating
HDAC5 from cell lysates of NRVM which, relative to ARVM,
exhibit more abundant expression of HDAC5. Consistent with
A IP: GFP
25
150
50
75
37
–
–
–
+
–
–
–
+
–
–
+
+
kDa
IB: GFP
IB: GFP-HDAC5
IB: B55α
IB: PP2AC
IB: PP2AA
AdV-GFP:
AdV-GFP-HDAC5:
ISO (10 nM):
B
kDa
– + – +ISO (1 μM):
siRNA: Scr B55α
pS259 HDAC5
150
GFP-HDAC5
150
B55α
GAPDH
50
37
Figure 6. B55a targets PP2A to HDAC5 for dephosphorylation. A, ARVM expressing GFP or GFP-HDAC5 were treated with 10 nmol/L
isoproterenol (ISO) or vehicle control (CON) for 10 minutes. GFP/GFP-HDAC5-containing complexes were immunoprecipitated from cell lysates,
separated by SDS-PAGE and the resulting Western blots probed for B55a, PP2AC, and PP2AA. Representative Western blots and grouped data
from 4 independent experiments. Unpaired t tests. *P<0.05 vs CON. B, NRVM expressing GFP-HDAC5 were transfected with scrambled (Scr) or
PPP2R2A (B55a) siRNAs for 48 hours prior to treatment with 1 lmol/L ISO or CON for 60 minutes. Representative Western blots and grouped
data from 4 independent experiments. Two-way ANOVA following by Sidak’s multiple comparisons tests. For B55a: *P<0.05 vs Scr within the
same treatment group (CON/ISO). For S259: *P<0.05 vs CON within the same siRNA group (Scr/B55a). AdV indicates adenovirus; ARVM, adult
rat ventricular myocytes; GFP, green ﬂuorescent protein; HDAC5, histone deacetylase 5; NRVM, neonatal rat ventricular myocytes; PP2A, protein
phosphatase 2A.
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our ﬁndings in ARVM expressing GFP-HDAC5, B55a associ-
ated with endogenous HDAC5 in NRVM, and the interaction
increased with isoproterenol (Figure S5). These ﬁndings
indicate that activation of b-AR signaling in cardiomyocytes
promotes the association of B55a-PP2A with HDAC5 and
suggest that this may be a key mechanism underlying
isoproterenol-induced HDAC5 dephosphorylation. Recruit-
ment of the PP2A holoenzyme to HDAC5 by B55a is likely
to occur in the cytosol, as subcellular fractionation of ARVM
revealed that B55a is present almost exclusively in the
soluble fraction, and does not translocate to the insoluble
fraction upon isoproterenol stimulation (Figure S6).
To assess the importance of B55a-PP2A in mediating
isoproterenol-induced dephosphorylation of HDAC5, we
designed an siRNA experiment to reduce the expression of
B55a. As conventional transfection is ineffective in ARVM,
and B55a targeting of HDAC5 appears to be conserved in
NRVM (Figure S5), we introduced siRNAs targeting PPP2R2A
transcripts into NRVM expressing GFP-HDAC5. This resulted
in a 50% to 55% reduction in B55a protein levels
(Figure 6B). Treatment with 1 lmol/L isoproterenol for
1 hour caused a signiﬁcant reduction in S259 phosphoryla-
tion that was abolished by B55a knockdown (Figure 6B),
suggesting that B55a is required for PP2A-mediated dephos-
phorylation of HDAC5 downstream of b-AR stimulation.
Isoproterenol had no effect on the phosphorylation of S279
or S498 in the absence or presence of B55a knockdown in
these experiments (Figure S7).
Phosphorylation-Independent Regulation of B55a
Downstream of b-AR Activation
Since the function of some PP2A B subunit isoforms, such as
B56d, is regulated through PKA-mediated phosphorylation,40
we also explored whether isoproterenol stimulation induces
the phosphorylation of B55a in ARVM. To achieve this, we
subjected protein samples from ARVM to PhosTag phosphate-
afﬁnity SDS-PAGE and immunoblot analysis.41 This revealed
increased phosphorylation of B56d, which is consistent with
previous data from other cell types,40 but not B55a, in
response to isoproterenol stimulation (Figure 7). Thus, iso-
proterenol-induced targeting of B55a to HDAC5 in ARVM is
unlikely to occur through increased phosphorylation of this B
subunit.
Discussion
The key ﬁndings of this study are that, in ARVM: (1)
isoproterenol stimulation induces the nuclear accumulation
of HDAC5, through a mechanism that requires PKA activity;
(2) The key determinant of HDAC5 subcellular localization is
the phosphorylation status of S259/S498, with loss of
phosphorylation at these sites promoting nuclear accumula-
tion and repression of MEF2; (3) The phosphorylation status
of S279 plays a relatively insigniﬁcant role in regulating the
nuclear versus cytoplasmic distribution of HDAC5; and (4)
Dephosphorylation of HDAC5 following b-AR activation
requires PP2A activity. In addition, our data provide evidence
that the regulatory subunit isoform B55a targets PP2A to
HDAC5 downstream of b-AR stimulation in cardiomyocytes,
and is required for the dephosphorylation of HDAC5 at S259.
Collectively, these ﬁndings may have important implications
regarding the molecular mechanisms underlying cardiomy-
ocyte responses to b-AR stimulation in physiological and
pathological settings.
Our ﬁndings concerning PP2A-mediated dephosphorylation
of HDAC5 add signiﬁcantly to data from an earlier study in
NRVM, which has shown that pretreatment with the PP2A
inhibitor OKA inhibits the ability of isoproterenol stimulation
to attenuate HDAC5 phosphorylation in response to GqPCR
stimulation.30 Firstly, we show that b-AR stimulation triggers
HDAC5 dephosphorylation even in the absence of GqPCR
stimulation. Secondly, we provide data indicating that, upon
b-AR stimulation, B55a is likely to target the PP2A holoen-
zyme to HDAC5 to facilitate its dephosphorylation at the key
regulatory phospho-acceptor residues. The mechanism by
which b-AR stimulation induces an increased B55a-PP2A/
HDAC5 association in cardiomyocytes requires further inves-
tigation. In this regard, recent crystallographic analyses of the
37
50
75
ISO:
IB: B55α IB: B56δ
SDS-PAGE PhosTag SDS-PAGE
IB: B55α IB: B56δ
– + – + – +
kDa
– +
Figure 7. B55a is not phospho-regulated downstream of b-AR
activation. Lysates from ARVM treated with vehicle control or
10 nmol/L isoproterenol (ISO) for 10 minutes were subjected to
standard SDS-PAGE or PhosTag phosphate-afﬁnity SDS-PAGE.
Duplicate sets of samples were run on the same gels for
subsequent immunoblotting with antibodies against B55a and
B56d. Unlike B56d, B55a is not phosphorylated in response to
ISO treatment (multiple bands in ISO sample on PhosTag blot
probed for B56d; absence of multiple bands in ISO sample on
PhosTag blot probed for B55a). b-AR indicates b-adrenergic
receptor; ARVM, adult rat ventricular myocytes.
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B55a-PP2A complex have deﬁned not only the structure of
the holoenzyme but also the likely binding interfaces between
the B55a subunit and another phosphoprotein substrate of
B55a-PP2A, Tau.42 The pertinent data indicate that the likely
binding site for Tau is a central groove on the top face of B55a
and that a cluster of amino acids on one side of this groove
play a critical role in binding.42 Importantly, individual
mutations of such amino acids had a dramatic impact on
the ability of the holoenzyme to bind to and dephosphorylate
Tau.42 On the assumption that the interaction of B55a-PP2A
with HDAC5 occurs in a similar manner, posttranslational
modiﬁcation of certain residue(s) within the substrate-binding
surface of B55a may provide a mechanism through which b-
AR stimulation promotes B55a-PP2A targeting to HDAC5,
although our data from PhosTag phosphate afﬁnity analysis
suggest that isoproterenol stimulation does not induce a
marked increase in B55a phosphorylation. Alternatively,
posttranslational modiﬁcation of B55a-interacting residues
within HDAC5 may play a role in this phenomenon. In that
regard, Tau appears to possess two nonoverlapping peptide
segments that are capable of binding to the B55a-PP2A
holoenzyme, which has been proposed to facilitate the
dephosphorylation of hyperphosphorylated Tau that contains
multiple phosphorylated Ser/Thr residues throughout its
sequence.42 In analogy, although the focus of our present
work and other related studies has been on the roles of 3
distinct phospho-acceptor residues (S259, S279, and S498),
proteomics analysis indicates that HDAC5 may contain at
least 17 phosphorylated Ser/Thr residues,7 whose regulation
and functional roles remain largely unknown.
Backs and colleagues43 have published convincing evi-
dence that PKA activation in cardiomyocytes induces the
generation of an N-terminal cleavage product of another class
IIa HDAC, HDAC4, and that this cleavage product (termed
HDAC4-NT) binds to and inhibits MEF2 in the nucleus. Based
on these ﬁndings, Backs et al43 have proposed that the
generation of HDAC4-NT during repetitive transient sympa-
thetic activation, as occurs during exercise training, would
inhibit MEF2 activation and consequent pathological cardiac
remodeling driven by MEF2-regulated genes.43 They have also
speculated that the therapeutic beneﬁt afforded by b-AR
antagonists in human heart failure may arise, at least in part,
through the attenuation of b-AR desensitization and conse-
quently greater HDAC4-NT generation downstream of b-AR
stimulation.43 It is possible that the b-AR/PKA/B55a-PP2A-
mediated dephosphorylation and consequent nuclear accu-
mulation of HDAC5 that we have uncovered in the present
study provides a complementary protective mechanism
against maladaptive cardiomyocyte hypertrophy and patho-
logical cardiac remodeling, through the inhibition of MEF2
activity (Figure 8), although this requires further investigation.
Of direct relevance to the potential protective effects of b-AR-
mediated generation of HDAC4-NT and dephosphorylation of
HDAC5 are the earlier observations of Perrino et al,44 who
reported that although exercise training and intermittent left
ventricular pressure overload both induced comparable
increases in circulating norepinephrine and epinephrine (the
endogenous b-AR agonists), only the latter stimulus led to b-
AR dysfunction and thereby produced a pathological cardiac
phenotype. Determination of the physiological role of b-AR/
PKA/B55a-PP2A-mediated dephosphorylation and nuclear
accumulation of HDAC5 requires the development of exper-
imental approaches to speciﬁcally interfere with cardiac B55a
and/or its targeting to HDAC5 upon b-AR stimulation in an
in vivo setting, which is a focus of our ongoing work. In this
context, it is interesting to note recent evidence suggesting
that B55a may dissociate from the core A/C dimer of PP2A in
failing canine myocardium as a consequence of increased
phosphorylation and/or reduced methylation of the C
subunit,39 which, based on our ﬁndings, would be expected
to lead to the attenuation of b-AR/PKA/B55a-PP2A-mediated
dephosphorylation and of the consequent nuclear accumula-
tion of HDAC5.
The cellular imaging methodology that we have established
and utilized in the present study provides the opportunity to
objectively determine the nuclear versus cytoplasmic distri-
bution of ﬂuorescently tagged proteins in live cardiomyocytes,
or indeed any other cell type, through the concomitant use of
ﬂuorescent dyes with distinct spectral properties (DRAQ5,
which intercalates with DNA, and Cell Tracker Orange, which
is retained in the cytoplasm) to demarcate the nuclear
compartment and the remainder of the cellular volume. A key
advantage of this methodology is the ability to monitor total
ﬂuorescence in each compartment across the entire cell,
without the potential subjectivity that arises from the use of
investigator-selected regions of interest and/or z-section,
variations in both of which we have found to have a marked
impact on the intensity of the GFP-HDAC5 ﬂuorescence
signal. Application of this method has allowed us to deﬁni-
tively determine the impact of isoproterenol stimulation on
HDAC5 nucleocytoplasmic shuttling in adult cardiomyocytes,
and to interrogate the roles of the S259/S498 and S279
phosphorylation sites in regulating HDAC5 localization. Our
ﬁndings regarding the impact of isoproterenol stimulation on
the subcellular distribution of HDAC5 are consistent with the
earlier reports of Ha et al,18 who studied NRVM stimulated
with forskolin (which elevates cAMP by activating adenylyl
cyclase), cAMP, or isoproterenol (1 lmol/L), and Chang
et al,19 who studied adult rabbit ventricular myocytes stim-
ulated with forskolin or isoproterenol (100 nmol/L), which
both suggested that activation of the b-AR/PKA pathway
promotes the nuclear retention of HDAC5. Where our study
differs markedly from such work is on the molecular
mechanism(s) underlying the nuclear accumulation of HDAC5
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in response to activation of the b-AR/PKA pathway. Both Ha
et al18 and Chang et al19 proposed PKA-mediated phospho-
rylation of S279 (erroneously referred to as S280 in Ha
et al18) to be the principal underlying mechanism. However, it
is important to note that neither study provided direct
evidence for such phosphorylation occurring following activa-
tion of the b-AR/PKA pathway in cardiomyocytes, and their
common proposed mechanism was based on observations
made with mutated versions of HDAC5 carrying nonphospho-
rylatable (S279A) or phospho-mimetic (S279D) substitutions
at the pertinent site.18,19 In the present study, we provide
novel evidence from the use of a phospho-speciﬁc antibody,
which we have conﬁrmed to speciﬁcally recognize HDAC5
phosphorylation at S279, that isoproterenol-induced
activation of the b-AR/PKA pathway in ARVM produces no
increase in the phosphorylation of this site. To the contrary,
and in common with the S259/S498 sites (Haworth et al17
and the present study), phosphorylation of the S279 site
declines rapidly and to a signiﬁcant extent upon isoproterenol
stimulation, and this dephosphorylation response is main-
tained for at least 60 minutes. Our ﬁndings are consistent
with a previous study in striatal neurons, which reported
reduced phosphorylation of all three sites following forskolin
treatment.33 Notably, in our work, we used isoproterenol at a
concentration of 10 nmol/L, which is 10- or 100-fold lower
than the concentrations used by Chang et al19 and Ha et al,18
respectively. In ARVM, 10 nmol/L isoproterenol induces
marked b-AR-mediated physiological responses, such as the
β-AR
PKA
ISO
HDAC5
S259 S279 S498
P P P
HDAC5
S259 S279 S498
B55α-PP2A Protease HDAC4
x
HDAC4-NTRepression of 
MEF2-dependent 
gene transcription MEF2MEF2
Figure 8. Working model for the regulation of class IIa histone deacetylases downstream of b-AR
activation in adult cardiomyocytes. Acute stimulation of b-adrenergic receptors (b-ARs) does not lead to
nuclear accumulation of HDAC5 through PKA-dependent phosphorylation of HDAC5 at S279, as previously
proposed.18,19 Rather, activation of b1-ARs in adult cardiomyocytes leads to PP2A-mediated dephospho-
rylation of HDAC5 at S259/S498 and S279, likely following the recruitment of PP2A to HDAC5 by the
regulatory subunit B55a. Dephosphorylation of S259/S498 is the key driver of HDAC5 nuclear
accumulation downstream of b1-AR/PKA activation in ARVM. This mechanism may act in concert with
the PKA-dependent formation of an N-terminal HDAC4 cleavage product (HDAC4-NT)43 to repress MEF2-
dependent gene transcription in settings of acute/transient b-adrenergic receptor stimulation. ARVM
indicates adult rat ventricular myocytes; b-AR, b-adrenergic receptor; HDAC5, histone deacetylase 5; MEF2,
myocyte enhancing factor-2; PKA, protein kinase A; PP2A, protein phosphatase 2A.
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potentiation of sarcomere shortening and intracellular
[Ca2+] transient amplitude29,45 and myoﬁlament protein
phosphorylation,45,46 providing the rationale for our selection
of this concentration in exploring the effects of isoproterenol
on HDAC5 phosphorylation and localization. Determination of
whether a different effect on HDAC5 phosphorylation at S279
might arise from the use of supra-physiological concentra-
tions of isoproterenol is beyond the scope of this study.
In our previous work utilizing wideﬁeld ﬂuorescence
microscopy and the quantiﬁcation of ﬂuorescence intensity
in selected regions of interest, we reported the same
concentration of isoproterenol (10 nmol/L) to induce GFP-
HDAC5 nuclear export in ARVM,17 which appears at odds with
our current ﬁndings. Interestingly, in the course of the present
work, we observed that while isoproterenol stimulation
induced a decline in Fcyto and increases in Fnuc and Fnuc/
Fcyto across the whole cell without impacting on Fcell
(Figures 2 and 3), it also led to the appearance of GFP-
HDAC5-containing puncta in the cytoplasm of 60% of the
cells that were imaged (Figure S8). These puncta were
numerous and very bright relative to the GFP-HDAC5
ﬂuorescence in the surrounding cytoplasmic compartment
(Figure S8). Furthermore, they did not arise from baseline
mislocalization of GFP-HDAC5 (Figure S9) and did not occur
with time-matched vehicle treatment or in ARVM expressing
GFP alone. As wideﬁeld ﬂuorescence microscopy also
captures secondary ﬂuorescence emitted from beyond the
focal plane, the generation of such bright puncta and their
impact on the measured Fcyto are likely to have contributed to
the apparent isoproterenol-induced decrease in Fnuc/Fcyto in
our previous study.17 The nature and potential biological
signiﬁcance of these isoproterenol-induced GFP-HDAC5-con-
taining puncta are currently unknown. Based on previous work
in our laboratory17 and by others,47 however, it is possible
that redox modiﬁcation of reactive cysteine residues in
HDAC5 may play a causal role in their appearance.
To conclude, in the present study, we describe a new
method for studying the nuclear versus cytoplasmic localiza-
tion of GFP-HDAC5 in adult cardiomyocytes, which has
allowed us to conclusively demonstrate that b-AR stimulation
induces the nuclear accumulation of HDAC5 through a
mechanism that requires PKA activity. Furthermore, we show
that dephosphorylation of S259/S498 in HDAC5 is the key
mechanism that triggers nuclear accumulation, and that such
dephosphorylation occurs downstream of the b1-AR subtype
and requires both PKA and PP2A activity, with the latter
targeted to HDAC5 through the PP2A regulatory subunit
B55a. These ﬁndings reveal new avenues of investigation
toward a better understanding of the molecular mechanisms
through which altered sympathetic activity and b-AR signaling
impact on cardiac phenotype, particularly in the context of
cardiac remodeling.
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 Data S1.
SUPPLEMENTAL METHODS 
Materials 
The following reagents were used: laminin (Sigma L2020), M199 (Gibco 22350-029), DMEM (Gibco 
11995-065), foetal bovine serum (Gibco 10099-141), carnitine (Sigma C9500), creatine (Sigma C0780), 
taurine (Sigma T0625), isoprenaline (ISO; Sigma I5627), CGP-20712A (CGP; Sigma C231), ICI 118,551 
(ICI; Sigma I127), N6-benzoyl cAMP (BNZ; Calbiochem 116802), 8-CPT-2’-O-Me-cAMP (CPT; 
Calbiochem 116833), H89 (Calbiochem, 371962), okadaic acid (OKA; Calbiochem 459620), EDTA-free 
protease inhibitor cocktail (Roche 11873580001), phosphatase inhibitor cocktail 3 (Sigma P0044). The 
adenoviral vectors used to express WT GFP-HDAC5, S259/498A GFP-HDAC5 and the MEF2-luciferase 
reporter were kind gifts from Dr Timothy McKinsey (University of Colorado, USA). The S279A GFP-
HDAC5 adenoviral vector was a kind gift from Dr Julie Bossuyt (UC Davis, USA). Adult male Wistar 
rats (300-324 g) were from Harlan Laboratories (United Kingdom) and Sprague-Dawley rats (1-2 day-
old neonates) were from Monash Animal Research Platform (Melbourne, Australia). 
ARVM isolation, culture and adenoviral transduction 
ARVM were isolated and plated on laminated 6-well culture plates as previously described.1 Two hours 
post-plating, the culture medium was replaced with modified M199 medium (M199 medium 
supplemented with 2 mM L-carnitine, 5 mM creatine, 5 mM taurine and penicillin/streptomycin) 
containing the appropriate multiplicity of infection (MOI) of adenovirus. The following MOI were used 
to express GFP or GFP-tagged HDAC5 variants: 3 pfu/cell GFP, 3 pfu/cell WT GFP-HDAC5; 30 pfu/cell 
S259/498A GFP-HDAC5; 10 pfu/cell S279A GFP-HDAC5. Transduced ARVM were maintained in 
culture for two days prior to experimentation. For the MEF2-luciferase reporter assay, ARVM were 
transduced with adenoviral vectors for GFP or GFP-HDAC5 variants as above and with 500 pfu/cell 
MEF2-luciferase adenovirus 18 hours later. ARVM were cultured for a further 24 hours prior to 
experimentation.  
MEF2 reporter assay 
ARVM expressing the GFP-HDAC5 variants or GFP alone and transduced with the MEF2-luciferase 
reporter (see above) were washed with cold PBS and lysed for 3 minutes on ice in PBS containing 1% 
Triton X-100, EDTA-free protease inhibitor cocktail and phosphatase inhibitor cocktail 3. The protein 
concentration of cell lysates was determined by Bradford assay using Protein Assay Dye Reagent (Bio-
Rad, 500-0006). 25 µg total protein was incubated with 70 µL ONE-Glo luciferase substrate (Promega, 
E6110) and the luminescence measured using a GloMax 20/20 Luminometer (Promega) after 10 
minutes. Luminescence measurements were normalized to an internal control (ARVM expressing the 
MEF2-luciferase reporter in the absence of GFP-HDAC5 or GFP) to allow data to be pooled from two 
independent experiments. Lysates were run on SDS-PAGE gels and the resulting Western blots probed 
with an anti-GFP antibody to verify that the GFP-HDAC5 variants were expressed to similar levels.  
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Western blotting 
ARVM plated at equivalent densities in 6-well cell culture plates were lysed in 150 µL Laemmli buffer. 
Proteins were separated by SDS-PAGE and transferred to PVDF membranes for Western blotting. 
Replicate membranes were probed with antibodies against phosphorylated and total protein species. The 
following antibodies were used to detect proteins of interest: phospho-S259 HDAC5 (Cell Signaling 
3443; 1:1000), phospho-S498 HDAC5 (Abcam 47283; 1:1000), GFP (Roche 11814460001; 1:5000), 
HDAC5 (Cell Signaling 20458; 1:1000), phospho-S22/23 TnI (Cell Signaling 4004; 1:1000), TnI (Cell 
Signaling 2002; 1:2000), B55α (Santa Cruz sc-81606; 1:500), B56α (BD Transduction 610615; 1:500), 
B56δ (Bethyl A301-100A; 1:1000), PP2AA (Santa Cruz sc-74580; 1:1000), PP2AC (Cell Signaling 2038; 
1:1000). The phospho-S279 HDAC5 antibody (raised against phospho-S266 HDAC4) was a kind gift 
from Dr Xiang-Jiao Yang (McGill University, Canada). The normalization by sum method was used to 
group data from biological replicates.2  
Subcellular fractionation 
ARVM were fractionated using a method adapted from Snabaitis et al.3 Briefly, ARVM were lysed in 
lysis buffer (50 mM Tris-HCl pH 7.5, 5 mM EGTA, 2 mM EDTA, 100 mM NaF, 1% Triton X-100, 
EDTA-free protease inhibitor tablet) on ice for 5 minutes then centrifuged at 14,000 g at 4°C for 30 
minutes. The supernatant (containing cytosolic proteins such as GAPDH; “soluble fraction”) was 
collected, and the pellet (containing nuclear proteins such as histone 2B; “insoluble fraction”) was 
resuspended in Laemmli buffer. Samples were resolved on 4-20% SDS-PAGE gels for subsequent 
Western blotting.  
Co-immunoprecipitation of GFP-HDAC5 with PP2A subunits 
ARVM were washed in cold PBS and lysed in a high salt lysis buffer (20 mM HEPES-KOH pH 7.4, 250 
mM NaCl, 0.11 M KOAc, 2 mM MgCl2, 1 µM ZnCl2, 1 µM CaCl2, 0.5% Triton X-100, 0.1% Tween-20, 
500 units/mL Benzonase nuclease (Sigma E1014), EDTA-free protease inhibitor tablet, phosphatase 
inhibitor cocktail 3) on ice for 3 minutes, then at room temperature for 10 minutes to activate the DNase, 
as previously described.4 Cells were scraped and samples vortexed before being incubated on ice for a 
further 10 minutes. Whole cell lysates were centrifuged at 8,000 g at 4°C for 10 minutes, and the NaCl 
concentration of the resulting supernatant adjusted to 150 mM with NaCl-free lysis buffer. 750 µg of each 
sample was incubated with uncoupled agarose beads (Chromotek bab-20) for 1 hour at 4°C. The beads 
were pelleted and the cleared supernatants immunoprecipitated at 4°C overnight using a GFP-Trap A kit 
(Chromotek gta-20). The next day, immunoprecipitates were washed and resuspended in Laemmli buffer 
for SDS-PAGE, as previously described.5  
Detection of endogenous HDAC5-B55α  complex 
NRVM were isolated from 1-2 day old Sprague Dawley rat pups as previously described6 and plated in 
DMEM containing 10% foetal bovine serum and penicillin/streptomycin at a density of 3.5x106 cells per 
10 cm cell culture dish. The day after plating, the media was replaced with maintenance media (4:1 
DMEM:M199) and the cells cultured for a further 24 hours prior to treatment with 1 µM ISO or vehicle 
for 60 minutes. Cells were washed in cold PBS and lysed in lysis buffer (30 mM HEPES, 150 mM NaCl, 
2 mM MgCl2, 2% Triton X-100, 50 mM NaF, 0.2 mM Na3VO4, 1 mM PMSF, 5 µM Pepstatin A) on ice 
for 10 minutes. Lysates were centrifuged at 8,000 g at 4°C for 10 minutes and 500 µg of the resulting 
supernatant incubated with Protein A Sepharose CL-4B beads (GE Healthcare, 17-0780-01) for 1 hour at 
4°C. The beads were pelleted and the cleared supernatants incubated with HDAC5 antibody (Cell 
Signaling 20458; 1:70) or water (no antibody control) with gentle rocking at 4°C overnight. The next day, 
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Protein A beads were added and the samples rocked at 4°C for 1 hour. The beads were washed four times 
in lysis buffer and then resuspended in Laemmli buffer for SDS-PAGE. 
siRNA knockdown of B55α  in NRVM 
NRVM were isolated and plated in 6-well cell culture plates at a density of 350,000 cells/well as 
described above. The day after plating, NRVM were transduced with WT GFP-HDAC5 adenovirus and 
incubated in serum-free DMEM overnight. NRVM were transfected with 10 nM PPP2R2A siRNA 
(Dharmacon, L-047957-00-0005) or a non-targeting siRNA pool (Dharmacon, D-001810-10-05) using 
Lipofectamine RNAiMAX Transfection Reagent (Invitrogen, 13778-150), according to the 
manufacturer’s instructions. Transfected cells were maintained in serum-free DMEM at 37°C, 5% CO2 
for 48 hours prior to stimulation with 1 µM ISO or vehicle for 60 minutes and subsequent lysis for 
Western blotting.  
Quantification of GFP-HDAC5 nucleo-cytoplasmic shuttling 
ARVM were isolated, plated in laminated 35 mm imaging dishes (Ibidi, 81156) and transduced with 
adenoviruses as described above. The day after plating, ARVM were incubated with 0.1 µM Cell Tracker 
Orange CMRA Dye (Molecular Probes, C34551) for 15 minutes at 37°C, 5% CO2 and then incubated in 
fresh modified M199 media overnight. On the day of imaging, cells were imaged using a Nikon Ti-E 
(inverted) microscope equipped with a Yokogawa spinning disk and a Neo 5.5 sCMOS camera (Andor). 
A 60x/1.40 NA Plan Apo λ oil objective was used. Images were acquired using NIS Elements AR 4.2 
software. Cells were maintained at 37°C, 5% CO2 throughout the experiment via a CO2 chamber and a 
temperature-regulated Perspex box which housed the microscope stage and turret.  
The Cell Tracker signal was used to select ARVM for imaging to avoid unnecessary excitation of the 
GFP fluorophores and to prevent possible bias during the selection of cells based on the basal distribution 
of GFP-HDAC5. ARVM were not selected for imaging if they satisfied one or more of the following 
exclusion criteria: 1) cell is not adhered to the bottom of the dish; 2) cell is twitching/moving; 3) cell is 
balled up or is starting to ball up at one or both ends; 4) cell is overlapping another cell or is close to 
floating cells (as this interfered with thresholding of the Cell Tracker Orange signal for generation of a 
binary layer corresponding to the whole cell). After the XY coordinates and perfect focusing system 
(PFS) settings for 12-15 cells had been set, z-stacks spanning 36 µm (1.5 µm steps) were acquired using 
the 488 nm laser line to capture the baseline GFP-HDAC5 signal for each cell. Cells were treated with 
vehicle control or 10 nM ISO and GFP z-stacks repeated 15 minutes post-treatment. Thirty-five minutes 
post-treatment, 1 µM DRAQ5 (Biostatus, DR50050) was added to the cells to label the nuclei. Ten 
minutes after the addition of DRAQ5 (i.e. 45 minutes after the addition of ISO/vehicle), each cell was 
imaged using the 488 nm, 561 nm and 640 nm laser lines to excite the GFP, Cell Tracker and DRAQ5 
fluorophores, respectively.  
All imaged cells were quantified using NIS Elements AR 4.2 software unless they met one of the 
following exclusion criteria: 1) cell does not express GFP-HDAC5, 2) z-stack does not cover entire cell 
volume at one or more time points; 3) cell is rotated in XY plane in one or more time points (rotation is 
complicated to correct in volume analysis); 4) cell shrinks over the time course of the experiment (as this 
interfered with the application of binary layers across time points); 5) cell disappears from field of view 
over the course of the experiment; 6) the GFP signal is saturated in one or more time points; 7) GFP-
HDAC5 is clearly mislocalized at baseline (see Fig. S9). Using thresholding, the Cell Tracker and 
DRAQ5 signals from the final time point were used to generate binary volumes corresponding to the 
whole cell and nuclei, respectively. Subtraction of the nuclear binary volume from the whole cell binary 
volume generated a third binary volume corresponding to the cytoplasm. The binary volumes were then 
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used to determine average GFP fluorescence intensities in the nuclear, cytoplasmic and whole cell 
volumes at each time point.  
Quantification of fluorescent puncta 
The number of puncta was quantified using Fiji imaging analysis software.7 For each cell, the background 
was subtracted using a rolling ball radius of 50.0 pixels. A single z-section that approximately bisected at 
least one of the nuclei was selected from the baseline GFP z-stack and the threshold adjusted by altering 
the minimum intensity value until there was a light ‘salt and pepper’ effect within the cell (see Fig. S8A). 
The number of puncta in the resulting binary image was quantified by counting the number of 0.1–10 µm2 
objects using the ‘Analyze Particles’ function. Any artifacts (e.g. GFP fluorescence in the nuclei) were 
subtracted from the total object count. The same conditions were then used to quantify the number of 
puncta in the corresponding z-section from the 45 minute GFP z-stack. The entire analysis was performed 
blinded to treatment group and z-stacks from the 45 minute time point were not viewed by the user until 
the analysis was complete to eliminate possible bias in application of the threshold to the baseline z-
section image. 
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Figure S1. Specificity of antibodies for pS259, pS279 and pS498 in HDAC5. A, Region of human 
HDAC4 used to generate an antibody against phosphorylated S266 (Walkinshaw et al., 2013) and 
sequence alignment showing 100% amino acid identity with human HDAC5. The conserved PKA 
phosphorylation site (S266 in HDAC4; S279 in HDAC5) is underlined. B, Cell lysates from ARVM 
expressing GFP, wildtype (WT) GFP-HDAC5, or non-phosphorylatable (S259/498A; S279A) variants of 
GFP-HDAC5 were separated by SDS-PAGE and analysed by Western blotting. The pS266 HDAC4 
polyclonal rabbit antibody detected a band of the correct molecular weight in cells expressing WT and 
S259/498A GFP-HDAC5, but not in cells expressing S279A GFP-HDAC5 or GFP alone, demonstrating 
cross-reactivity with pS279 in HDAC5. Similarly, commercially available antibodies for pS259 (Cell 
Signaling 3443) and pS498 (Abcam 47283) detected bands of the correct molecular weights in cells 
expressing WT and S279A GFP-HDAC5, but not in cells expressing S259/498A GFP-HDAC5 or GFP 
alone. GFP and GFP-HDAC5 were detected by immunoblotting with an anti-GFP antibody (Roche, 
11814460001).  
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Figure S2. Selective activation of PKA in ARVM using N6-benzoyl cAMP. Troponin I (TnI) 
phosphorylation was used as a readout of PKA activity in ARVM treated with isoprenaline (ISO) for 10 
min, or with N6-benzoyl cAMP (BNZ), 8-CPT-2’-O-Me-cAMP (CPT) or vehicle control (CON) for 30 
min. A, 500 µM BNZ induced a similar increase in TnI phosphorylation as 10 nM ISO. B, BNZ treatment 
increased TnI phosphorylation, whereas equivalent concentrations of CPT had no effect. C, 10 nM ISO 
and 500 µM BNZ reduced the phosphorylation of HDAC5 at all three sites, whereas 500 µM CPT had no 
effect.   
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Figure S3. Variability associated with measurement of GFP-HDAC5 nuclear and cytoplasmic 
fluorescence intensities in live ARVM. A, An ARVM expressing GFP-HDAC5 was imaged as 
described in Materials and Methods. Five sequential z-sections from an individual cell are shown. The 
fluorescent signal from GFP-HDAC5 was used to define the cell boundary (solid white line), the nuclear 
boundaries (dashed red and yellow lines) and example regions of interest (ROI) within the cytoplasm 
(dashed white lines). Scale bar is 10 µm. B, Measurements of the nuclear fluorescence can vary markedly, 
depending on the focal plane and the nucleus chosen for quantification. Graph shows average 
fluorescence intensity (F) measurements from three binucleated cells. Measurements were obtained from 
three sequential z-sections per nucleus (red and yellow data points for Cell 1 correspond to the red and 
yellow ROI in panel A). C, There is variability associated with sampling small ROI within the cytoplasm. 
Graph shows F measurements for eight ROI per z-section from sequential z-sections of the cell shown in 
panel A.  
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Figure S4. B55α  associates with GFP-HDAC5. A, Protein lysates (5-15 µL) from ARVM were 
separated by SDS-PAGE and the resulting Western blot probed with a mouse monoclonal antibody raised 
against rat B55α (Santa Cruz sc-81606). B, Protein lysates from ARVM expressing GFP, GFP-HDAC5 
or neither were immunoprecipitated using a GFP-Trap kit (Chromotek, gta-20). Immunoprecipitates were 
separated on SDS-PAGE gels and the resulting Western blots probed with antibodies against GFP, B55α, 
B56α and B56δ.    
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Figure S5. ISO increases the association between endogenous HDAC5 and B55α . HDAC5-
containing complexes were immunoprecipitated from NRVM cell lysates following treatment with 1 µM 
isoprenaline (ISO) or vehicle (VEH) for 60 minutes and the resulting Western blots probed for HDAC5 
and B55α. Representative Western blots and grouped data from three independent experiments. Unpaired 
t-test. * P<0.05 vs VEH.
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Figure S6. Subcellular distribution of B55α  in ARVM. ARVM were fractionated into Triton X-100-
soluble (SOL) and -insoluble (INSOL) fractions via centrifugation following treatment with 10 nM 
isoprenaline (ISO) or vehicle control (CON) for 45 minutes. Representative Western blots and 
quantitative data from four independent experiments. In each experiment, the B55α signal in CON and 
ISO fractions was normalised to the signal in the respective inputs. No significant differences were 
detected by unpaired t-test. The GAPDH and histone 2B blots are the same as those that appear in Fig. 2D 
as the same Western blot was probed for B55α. 
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Figure S7. ISO had no effect on S279 and S498 phosphorylation in NRVM. NRVM expressing GFP-
HDAC5 were transfected with scrambled (Scr) or PPP2R2A (B55α) siRNAs for 48 hours prior to 
treatment with 1 µM ISO or CON for 60 minutes. Grouped data from four independent experiments. No 
significant differences were detected by two-way ANOVA. 
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Figure S8. Quantification of GFP-HDAC5-containing puncta in ARVM treated with 10 nM ISO. A, 
Screenshots from Fiji analysis of GFP-HDAC5-containing puncta in live ARVM at baseline and 45 
minutes after the addition of 10 nM isoprenaline (ISO). B, C, Quantification of 0.1-10 µm2 objects at 
baseline (B) and following treatment with vehicle (VEH) or isoprenaline (ISO) for 45 minutes (C). n=25-
27 cells from two hearts per group. The median and interquartile range are shown. Mann-Whitney tests; 
ns: not significant.    
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Figure S9. Examples of mislocalized GFP-HDAC5 in ARVM. Maximum intensity projections of 
ARVM transduced with adenoviruses to express GFP-HDAC5. Z-stacks were acquired as described in 
Methods. A, Examples of cells that were included in the analysis of GFP-HDAC5 nucleo-cytoplasmic 
shuttling. B, Examples of cells that were excluded from the post-imaging analysis of GFP-HDAC5 
nucleo-cytoplasmic shuttling due to the mislocalization of heterologously-expressed GFP-HDAC5 at 
baseline. Scale bar is 20 µm.    
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